Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaoling Deng has a total of 94 co-authors. Here are the top co-authors by number of shared publications:

  • Fan Liu

    Department of Basic Medical Science, School of Medicine, Xiamen University, Xiamen, China

    10 shared publications
  • Mingyan Xu

    Department of Implantology&Prosthodontics, Stomatological Hospital of Xiamen Medical College, Xiamen Key Laboratory of Stomatological Disease Diagnosis and Treatment, Xiamen, China

    10 shared publications
  • Feixiang Zhu

    Department of Implantology&Prosthodontics, Stomatological Hospital of Xiamen Medical College, Xiamen Key Laboratory of Stomatological Disease Diagnosis and Treatment, Xiamen, China

    5 shared publications
  • Songlin Shi

    Department of Basic Medical Science, School of Medicine, Xiamen University, Xiamen, China

    5 shared publications
  • Hongfa Yao

    Department of Implantology&Prosthodontics, Stomatological Hospital of Xiamen Medical College, Xiamen Key Laboratory of Stomatological Disease Diagnosis and Treatment, Xiamen, China

    3 shared publications
  • Mingyan Xu

    Department of Implantology, Stomatological Hospital of Xiamen Medical College & Xiamen Key Laboratory of Stomatological Disease Diagnosis and Treatment, Xiamen 361008, China

    3 shared publications

Latest Publications

  • Open Access

    Immediate dental implants: insights into early and late failures from a large-scale Chinese cohort

    by Yiyun Yang, Lu Zhou, Xiaomei Hong, Mingfu Ye, Yang Yang, Xiaoling Deng, Mingyan Xu

    Immediate implant placement (IIP) has emerged as a time-efficient therapeutic approach in dentistry, offering advantages such as reduced treatment duration and improved alveolar bone preservation. However, concerns remain regarding early and late implant failures, and large-scale data on factors associated with IIP failure in Chinese populations are limited. This retrospective observational study aims to identify the factors associated with early and late failure of immediate dental implant. Patients who underwent immediate implantation at the Second Department of Implantology, Xiamen Stomatological Hospital, between January 2013 to December 2022, were retrospectively included. Cumulative survival rates (CSR) at the implant and patient levels were calculated using the life table method and presented with Kaplan-Meier survival curves. Cox regression analysis was performed to evaluate associations between implant failure and demographic, anatomical, surgical, and implant related variables. A total of 1513 implants placed in 781 patients were included. Of these, 50 experienced early failure and 36 experienced late failure. The 10-year CSR at implant level was 93.15% and at patient level 89.46%. Mean survival time was 47.34 ± 34.98 months (range 0-128 months). The mean patient age was 53.02 ± 14.02 years, comprising 46.46% females and 53.54% males. Multivariable analysis showed that male sex (HR = 2.48; 95% CI: 1.31-4.69), maxillary sinus elevation (HR = 2.49; 95% CI: 1.05-5.87), maxillary anterior implant position (HR = 3.15; 95% CI: 1.29-7.69), and maxillary posterior implant position (HR = 2.75; 95% CI: 1.08-6.98) were associated with higher rates of early implant failure, whereas submerged healing was associated with a lower rate of early failure (HR = 0.53; 95% CI: 0.30-0.95). For late implant failure, bone grafting without membrane coverage was associated with increased failure (HR = 3.54; 95% CI: 1.07-11.74), whereas implant diameter of 4.0-4.5 mm was associated with lower late failure compared with ≤ 3.75 mm implants (HR = 0.30; 95% CI: 0.13-0.69). In this large retrospective cohort of Chinese patients, IIP demonstrated favorable long-term survival. Several patient-related and surgical variables were associated with implant failure; however, causal inferences cannot be drawn due to the observational study design.

  • Open Access

    Single-cell RNA-seq combined with bulk RNA-seq analysis identifies necroptosis-related genes as therapeutic targets for periodontitis

    by Feixiang Zhu, Mingyan Xu, Yixin Xiao, Hongfa Yao, Fan Liu, Songlin Shi, Rui Huang, Qianju Wu, Xiaoling Deng

    Necroptosis, a regulated form of programmed cell death, exacerbates inflammatory responses by releasing damage-associated molecular patterns and inflammatory factors. However, the specific mechanisms underlying necroptosis in periodontitis remain largely unclear. This study integrated single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing (RNA-seq) data to identify core necroptosis-related genes (NRGs) and validated these findings using external datasets and periodontitis samples collected during our research. Overlapping genes were identified through a comparative analysis of 114 NRGs sourced from GeneCards and marker genes specific to various cell types in the single-cell GSE171213 periodontitis dataset. Based on these genes, cells were categorized into high- and low-necroptosis score groups. Key NRGs were identified through intersection analysis of differentially expressed genes in the high necroptosis group using the GSE10334 bulk RNA-seq dataset, followed by Kyoto Encyclopedia of Genes and Genomes (KEGG)/ Gene Ontology (GO) enrichment analysis. Machine learning further identified hub genes associated with the inflammatory response in periodontitis. Consensus clustering analysis, clinical diagnostic model construction, gene set variation analysis, and gene set enrichment analysis were performed based on these hub genes. The model’s predictive performance was validated using independent datasets and periodontitis tissue samples. We identified 10 cell types in periodontitis tissues and observed changes in the abundance of various cell populations in affected samples. Furthermore, we selected 35 NRGs differentially expressed in specific cell populations, with neutrophils and macrophages showing higher necroptosis scores. By integrating bulk RNA-seq data, we further identified 29 key NRGs. KEGG/GO analysis indicated their enrichment in inflammatory response signaling pathways. Machine learning highlighted six hub genes (CSF3R, CSF2RB, BTG2, CXCR4, GPSM3, and SSR4), all of which were highly expressed in periodontitis tissues. Consensus clustering based on these genes divided patients with periodontitis into two subgroups with distinct expression profiles. The clinical diagnostic model constructed based on these six key genes exhibited excellent diagnostic performance. Both external independent validation sets and clinical sample tests confirmed high expression of these six key genes in periodontitis tissues. Our study identified six hub genes (CSF3R, CSF2RB, BTG2, CXCR4, GPSM3, and SSR4) highly expressed in periodontitis tissues and positively correlated with necroptosis. These genes may serve as therapeutic targets for inflammatory diseases like periodontitis.


  • SRF and CBP jointly regulate integrin β6 overexpression in head and neck squamous cell carcinomas

    by Mingyan Xu, Gongwei Luo, Yixin Xiao, Feixiang Zhu, Hongfa Yao, Haohao Zhu, Fan Liu, Songlin Shi, Xiaoling Deng

  • Targeting circFOXO3 to Modulate Integrin β6 Expression in Periodontitis: A Potential Therapeutic Approach

    by Mingyan Xu, Feixiang Zhu, Yifan Guo, Fan Liu, Songlin Shi, Ling Yang, Rui Huang, Xiaoling Deng

    Aims: Circular RNA forkhead box O3 (circFOXO3) is crucial in regulating inflammation in lung and heart injuries. However, its role in periodontitis remains unclear. We sought to elucidate the effects of circFOXO3 on periodontitis progression and related molecular mechanisms. Methods: Reverse‐transcription quantitative polymerase chain reaction and fluorescence in situ hybridization were used to quantify and localize circFOXO3 expression. The mechanism by which circFOXO3 promotes inflammation in periodontitis was investigated using epithelial cells, human gingival epithelium and a rat model of ligature‐induced periodontitis. Results: circFOXO3 expression was abnormally high in the gingival epithelial tissues of patients with periodontitis. Elevated circFOXO3 levels down‐regulated microRNA (miR)‐141‐3p, leading to increased FOXO3 expression. FOXO3 interacted with JunB to form a transcriptional‐repression complex that inhibited the integrin β6 (ITGβ6)‐mediated activation of transforming growth factor β (TGF‐β) in epithelial cells. Through the miR‐141‐3p/FOXO3/JunB axis, circFOXO3 suppressed TGF‐β signalling, thereby exacerbating periodontal inflammation. Finally, circFOXO3 inhibition hindered disease progression and restored TGF‐β activity in vivo via the FOXO3/JunB/ITGβ6 pathway. Conclusion: Our study identified a novel mechanism by which circFOXO3 contributes to periodontal inflammation through a complex transcriptional regulatory network involving miR‐141‐3p, FOXO3, JunB and ITGβ6. These findings highlight potential therapeutic targets for the development of effective treatments for this debilitating disease.


  • BRG1 mediates epigenetic regulation of TNFα‐induced CCL2 expression in oral tongue squamous cell carcinoma cells

    by Mingyan Xu, Xuemei Lu, Feixiang Zhu, Xue Sun, Hongfa Yao, Junling Zhang, Weishi Chen, Haohao Zhu, Fan Liu, Song Lin Shi, et al.

    Strong evidence has indicated that upregulation of chemokine (CC motif) ligand‐2 (CCL2) expression and the presence of an inflammatory tumor microenvironment significantly contribute to the migratory and invasive properties of oral squamous cell carcinoma, specifically oral tongue squamous cell carcinoma (OTSCC). However, the precise epigenetic mechanism responsible for enhanced CCL2 expression in response to the inflammatory mediator tumor necrosis factor alpha (TNF‐α) in OTSCC remains inadequately elucidated. We have demonstrated that the production of CCL2 can be induced by TNF‐α, and this induction is mediated by the chromatin remodel protein BRG1. Through the use of a chromatin immunoprecipitation (ChIP) assay, we have found that BRG1 was involved in the recruitment of acetylated histones H3 and H4 at the CCL2 promoter, thereby activating TNF‐α‐induced CCL2 transcription. Furthermore, we have observed that recruitment of NF‐κB p65 to the CCL2 promoter was increased following BRG1 overexpression and decreased after BRG1 knockdown in OTSCC cells. Our Re‐ChIP assay has shown that BRG1 knockdown completely inhibits the recruitment of both acetylated histone H3 or H4 and NF‐κB to the CCL2 promoter. In summary, the findings of our study demonstrate that BRG1 plays a significant role in mediating the production of CCL2 in OTSCC cells in response to TNF‐α stimulation. This process involves the cooperative action of acetylated histone and NF‐κB recruitment to the CCL2 promoter site. Our data suggest that BRG1 serves as a critical epigenetic mediator in the regulation of TNF‐α‐induced CCL2 transcription in OTSCC cells.


  • Open Access

    MiR-199a-5p-Regulated SMARCA4 Promotes Oral Squamous Cell Carcinoma Tumorigenesis

    by Mingyan Xu, Junling Zhang, Xuemei Lu, Fan Liu, Songlin Shi, Xiaoling Deng

    SWI/SNF related, matrix associated, actin-dependent regulator of chromatin, subfamily a, member 4 (SMARCA4, also known as BRG1), an ATPase subunit of the switch/sucrose non-fermentable (SWI/SNF) chromatin remodeling complex, plays an important regulatory role in many cytogenetic and cytological processes during cancer development. However, the biological function and mechanism of SMARCA4 in oral squamous cell carcinoma (OSCC) remain unclear. The present study aimed to investigate the role of SMARCA4 in OSCC and its potential mechanism. Using a tissue microarray, SMARCA4 expression was found to be highly upregulated in OSCC tissues. In addition, SMARCA4 upregulate expression led to increased migration and invasion of OSCC cells in vitro, as well as tumor growth and invasion in vivo. These events were associated with the promotion of epithelial–mesenchymal transition (EMT). Bioinformatic analysis and luciferase reporter assay confirmed that SMARCA4 is a target gene of microRNA miR-199a-5p. Further mechanistic studies showed that the miR-199a-5p regulated SMARCA4 can promote the invasion and metastasis of tumor cells through EMT. These findings indicate that the miR-199a-5p- SMARCA4 axis plays a role in tumorigenesis by promoting OSCC cell invasion and metastasis through EMT regulation. Our findings provide insights into the role of SMARCA4 in OSCC and the mechanism involved, which may have important implications for therapeutic purposes.


  • Open Access

    Serum Response Factor-Regulated IDO1/Kyn-Ahr Pathway Promotes Tumorigenesis of Oral Squamous Cell Carcinoma

    by Mingyan Xu, Feixiang Zhu, Qi Yin, Hao Yin, Shaobin Fang, Gongwei Luo, Jie Huang, Wenxia Huang, Fan Liu, Ming Zhong, et al.

    Serum response factor (SRF) regulates pro-carcinogenic genes in various cancers, but its role in oral squamous cell carcinoma (OSCC) remains unclear. SRF expression in 70 OSCC samples was detected via immunohistochemistry. Abundant SRF expressed in OSCC tissues was closely associated with tumor metastasis. SRF-overexpressing OSCC cells were constructed to evaluate how SRF affects OSCC cell tumorigenesis and epithelial-to-mesenchymal transition (EMT) in vitro and in vivo. Overexpressed SRF increased OSCC cell migration and invasion in vitro and tumor growth and invasion in vivo. This promoted EMT, characterized by decreased and increased expression of E- and N-cadherin, respectively. Furthermore, an analysis of RNA sequences of transcriptional targets of SRF showed that SRF transactivated the indoleamine 2, 3-dioxygenase 1 (IDO1)/kynurenine-aryl hydrocarbon receptor (Kyn-AhR) signaling pathway in OSCC cell lines. Direct SRF binding to the IDO1 gene promoter upregulated transcription, which was detected through chromatin immunoprecipitation and dual luciferase reporter assays. Inhibiting IDO1 or AhR impaired SRF-induced migration and invasion and prevented EMT in OSCC cells. Our results demonstrated that SRF is a critical regulator of the IDO1/Kyn-AhR signaling pathway. This in turn increases OSCC cell migration and invasion by modulating EMT, which, consequently, favors OSCC cell growth and metastasis. We revealed a novel molecular mechanism through which SRF modulates OSCC metastasis. This should provide potential targets or biomarkers for OSCC diagnosis and treatment.


  • Open Access

    FOXO1 inhibits FSL-1 regulation of integrin β6 by blocking STAT3 binding to the integrin β6 gene promoter

    by Mingyan Xu, Jie Huang, Feixiang Zhu, Kailun Shen, Fan Liu, Xiaoling Deng

    Integrin β6 (ITGB6), an epithelial-specific receptor, is downregulated in the gingival epithelium of periodontitis and is associated with inflammation response and periodontitis development. However, the transcriptional regulatory mechanism of ITGB6 downregulation in the human gingival epithelium remains unclear. Fibroblast-stimulating lipopeptide-1 (FSL-1), an oral biofilm component, promotes an epithelial cell-driven proinflammatory response in periodontitis partially by suppressing ITGB6 expression. The aim of the current study was to investigate the transcriptional regulatory mechanism of ITGB6 inhibition by FSL-1 in human epithelial cells (HaCaT and primary human gingival epithelial cells), and to delineate the transcriptional mechanism of ITGB6 suppression in periodontitis. We found that FSL-1 inhibited ITGB6 transcription through increasing forkhead box protein O1 (FOXO1) expression and inhibiting signal transducer and activator of transcription 3 (STAT3) activation. Furthermore, FOXO1 bound to STAT3 directly, leading to decreased STAT3 phosphorylation induced by FSL-1. Consequently, the binding of phosphorylated STAT3 to the ITGB6 promoter was decreased, and ITGB6 transcription was therefore downregulated following FSL-1 stimulation. The reciprocal action of STAT3 and FOXO1 on ITGB6 downregulation was also confirmed by the immunostaining of the inflammatory epithelium associated with periodontitis. Our findings suggest that the interaction of FOXO1–STAT3 may be a useful signal target for the treatment of periodontitis.


  • Open Access

    Effect of cognitive behavioral therapy on anxiety and depression in patients with psoriasis

    by Chuan Tan, Jianmei Jiang, Xiaoling Deng, Wei Xiang, Tingting Mb Hu

    Background: Psoriasis can lead to higher social and psychological burden, and its occurrence is related to psychological disturbance. At present, there are many clinical trials on cognitive behavior therapy for depression and anxiety in patients with psoriasis. However, the results of studies vary greatly due to the different time and content of the intervention, and the curative effect is still controversial. Therefore, the purpose of this study was to explore the effect of cognitive behavior therapy on anxiety and depression in patients with psoriasis through meta-analysis. Methods: We searched Chinese and English databases to collect all randomized controlled trials of cognitive behavior therapy on anxiety and depression in patients with psoriasis until October 2021. Two researchers then independently screened articles, extracted data, and evaluated the quality of selected literatures. All data were processed by Stata 14.0. Results: The results will be published in peer-reviewed journals. Conclusion: Our study is expected to provide high-quality evidence-based medicine advice for the effects of cognitive behavior therapy on anxiety and depression in patients with psoriasis. Ethics and dissemination: Ethical approval was not required for this study. The systematic review will be published in a peer-reviewed journal, presented at conferences, and shared on social media platforms. This review would be disseminated in a peer-reviewed journal or conference presentations. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/APKVG.